Table 1 Baseline characteristics of the subjects
From: Effects of L-carnitine supplementation on lipid profiles in patients with coronary artery disease
Placebo (n = 19) | LC (n = 20) | |||
|---|---|---|---|---|
Mean | s.d. | Mean | s.d | |
Gender (male) | 19 | 20 | ||
Age (y) | 72.7 | 10.1 | 71.9 | 10.6 |
SBP (mmHg) | 127.3 | 6.0 | 128.4 | 10.4 |
DBP (mmHg) | 74.5 | 4.4 | 72.3 | 4.7 |
General obesitya (%) | 36.8 | 30.0 | ||
Central obesitya (%) | 84.2 | 65 | ||
Smokingb (n, %) | 3 (15.8 %) | 4 (20.0 %) | ||
Drinkingc (n, %) | 3 (15.8 %) | 3 (15.0 %) | ||
Dietary intake | ||||
Energy (kcal/day) | 1501.4 | 63.7 | 1534.2 | 41.6 |
Protein (g/day, % of total calories) | 54.2 (14.2) | 11.2 | 51.1 (12.9) | 6.9 |
Fat (g/day, % of total calories) | 43.3 (26.4) | 9.7 | 43.2 (23.8) | 10.6 |
SFA (g/day) | 11.7 | 5.3 | 10.6 | 5.4 |
PUFA (g/day) | 14.0 | 3.5 | 15.9 | 3.6 |
MUFA (g/day) | 13.3 | 3.8 | 13.0 | 4.9 |
Carbohydrate (g/day, % of total calories) | 225.3 (60.3) | 16.3 | 236.7 (63.5) | 24.7 |